1,511
Views
0
CrossRef citations to date
0
Altmetric
Research Article

New perspectives for investigating muscular perfusion response after dietary supplement intake: an exploratory, randomized, double-blind, placebo-controlled crossover trial in healthy young athletes using contrast-enhanced ultrasound (CEUS)

, ORCID Icon, , , & ORCID Icon
Pages 397-416 | Received 20 Dec 2021, Accepted 28 Jun 2022, Published online: 13 Jul 2022

References

  • Knapik JJ, Steelman RA, Hoedebecke SS, et al. Prevalence of dietary supplement use by athletes: systematic review and meta-analysis. Sports Med. 2016;46(1):103–123.
  • Jovanov P, Đorđić V, Obradović B, et al. Prevalence, knowledge and attitudes towards using sports supplements among young athletes. J Int Soc Sports Nutr. 2019;16(1):27.
  • Jin RC, Loscalzo J. Vascular nitric oxide: formation and function. J Blood Med. 2010;2010(1):147–162.
  • Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288(5789):373–376.
  • Brooks JR, Oketch-Rabah H, Low Dog T, et al. Safety and performance benefits of arginine supplements for military personnel: a systematic review. Nutr Rev. 2016;74(11):708–721.
  • Gonzales JU, Raymond A, Ashley J, et al. Does l-citrulline supplementation improve exercise blood flow in older adults? Exp Physiol. 2017;102:1661–71.
  • Tang JE, Lysecki PJ, Manolakos JJ, et al. Bolus arginine supplementation affects neither muscle blood flow nor muscle protein synthesis in young men at rest or after resistance exercise. J Nutr. 2011;141(2):195–200.
  • Alvares TS, Conte CA, Paschoalin VM, et al. Acute l-arginine supplementation increases muscle blood volume but not strength performance. Appl Physiol Nutr Metab. 2012;37(1):115–126.
  • Fahs CA, Heffernan KS, Fernhall B. Hemodynamic and vascular response to resistance exercise with L-arginine. Med Sci Sports Exerc. 2009;41(4):773–779.
  • Fox CD, Garner CT, Mumford PW, et al. Higher doses of a green tea-based supplement increase post-exercise blood flow following an acute resistance exercise bout in recreationally resistance-trained college-aged men. J Int Soc Sports Nutr. 2020;17(1):27.
  • Lorenz M, Rauhut F, Hofer C, et al. Tea-induced improvement of endothelial function in humans: no role for epigallocatechin gallate (EGCG). Sci Rep. 2017;7(1):2279.
  • Harvey CJ, Sidhu PS, Bachmann Nielsen M. Contrast-enhanced ultrasound in renal transplants: applications and future directions. Ultraschall Med. 2013;34(4):319–321.
  • Naehle CP, Steinberg VA, Schild H, et al. Assessment of peripheral skeletal muscle microperfusion in a porcine model of peripheral arterial stenosis by steady-state contrast-enhanced ultrasound and Doppler flow measurement. J Vasc Surg. 2015;61(5):1312–1320.
  • Fernandez CP, Ripolles T, Martinez MJ, et al. Diagnosis of acute cortical necrosis in renal transplantation by contrast-enhanced ultrasound: a preliminary experience. Ultraschall Med. 2013;34(4):340–344.
  • Klauser AS, Franz M, Arora R, et al. Detection of vascularity in wrist tenosynovitis: power Doppler ultrasound compared with contrast-enhanced grey-scale ultrasound. Arthritis Res Ther. 2010;12(6):R209.
  • Fischer C, Krix M, Weber MA, et al. Contrast-enhanced ultrasound for musculoskeletal applications: a world federation for ultrasound in medicine and biology position paper. Ultrasound Med Biol. 2020;46(6):1279–1295.
  • Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32(9):1369–1375.
  • Fischer C, Kunz P, Strauch M, et al. Safety profile of musculoskeletal contrast-enhanced ultrasound with sulfur hexafluoride contrast agent. Ther Clin Risk Manag. 2020;16:269–280.
  • Greis C. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc. 2011;49(1–4):137–149.
  • Kunz P, Kiesl S, Groß S, et al. Intra-observer and device-dependent inter-observer reliability of contrast-enhanced ultrasound for muscle perfusion quantification. Ultrasound Med Biol. 2020;46(2):275–285.
  • Fischer C, Gross S, Zeifang F, et al. Contrast-enhanced ultrasound determines supraspinatus muscle atrophy after cuff repair and correlates to functional shoulder outcome. Am J Sports Med. 2018;46(11):2735–2742.
  • Fischer C, Frank M, Kunz P, et al. Dynamic contrast-enhanced ultrasound (CEUS) after open and minimally invasive locked plating of proximal humerus fractures. Injury. 2016;47(8):1725–1731.
  • Fischer C, Krammer D, Hug A, et al. Dynamic contrast-enhanced ultrasound and elastography assess deltoid muscle integrity after reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2017;26(1):108–117.
  • Kellermann M, Heiss R, Swoboda B, et al. intramuscular perfusion response in delayed onset muscle soreness (doms): a quantitative analysis with contrast-enhanced ultrasound (CEUS). Int J Sports Med. 2017;38(11):833–841.
  • Kunz P, Mick P, Gross S, et al. Contrast-enhanced ultrasound (CEUS) as predictor for early retear and functional outcome after supraspinatus tendon repair. J Orthop Res. 2020;38(5):1150–1158.
  • Fischer C, Flammer S, Kauczor HU, et al. Preoperative deltoid assessment by contrast-enhanced ultrasound (CEUS) as predictor for shoulder function after reverse shoulder arthroplasty: a prospective pilot study. Arch Orthop Trauma Surg. 2020;140(8):1001–1012.
  • Tranquart F, Mercier L, Frinking P, et al. Perfusion quantification in contrast-enhanced ultrasound (CEUS)–ready for research projects and routine clinical use. Ultraschall Med. 2012;33(Suppl 1):S31–8.
  • Dietrich CF, Averkiou MA, Correas JM, et al. An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med. 2012;33(4):344–351.
  • Doll J, Bürkle F, Neide A, et al. Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: a study protocol. Medicine (Baltimore). 2020;99(41):e22318.
  • Teare MD, Dimairo M, Shephard N, et al. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;15(1):264.
  • Moinard C, Nicolis I, Neveux N, et al. Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. Br J Nutr. 2008;99(4):855–862.
  • Grimble GK. Adverse gastrointestinal effects of arginine and related amino acids. J Nutr. 2007;137(6):1693s–701s.
  • Apostol AT, Tayek JA. A decrease in glucose production is associated with an increase in plasma citrulline response to oral arginine in normal volunteers. Metabolism. 2003;52(11):1512–1516.
  • Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2003;9:3312–3319.
  • Suzuki T, Morita M, Hayashi T, et al. The effects on plasma L-arginine levels of combined oral L-citrulline and L-arginine supplementation in healthy males. Biosci Biotechnol Biochem. 2017;81(2):372–375.
  • Tan AEL, Grisbrook TL, Minaee N, et al. Predicting 1 repetition maximum using handheld dynamometry. PM R. 2018;10(9):934–941.
  • Krzysztofik M, Wilk M, Wojdała G, et al. Maximizing muscle hypertrophy: a systematic review of advanced resistance training techniques and methods. Int J Environ Res Public Health. 2019;16(24):4897.
  • Schoenfeld BJ. The mechanisms of muscle hypertrophy and their application to resistance training. J Strength Cond Res. 2010;24(10):2857–2872.
  • Buckner SL, Dankel SJ, Mattocks KT, et al. Differentiating swelling and hypertrophy through indirect assessment of muscle damage in untrained men following repeated bouts of resistance exercise. Eur J Appl Physiol. 2017;117(1):213–224.
  • https://www.esn.com/products/esn-l-citrullin-malat-500g. Accessed 15 May 2021.
  • Faria TO, Angeli JK, Mello LGM, et al. A single resistance exercise session improves aortic endothelial function in hypertensive rats. Arq Bras Cardiol. 2017;108(3):228–236.
  • Mota MM, Mesquita TR, Braga da Silva TL, et al. Endothelium adjustments to acute resistance exercise are intensity-dependent in healthy animals. Life Sci. 2015;142:86–91.
  • Casey DP, Ueda K, Wegman-Points L, et al. Muscle contraction induced arterial shear stress increases endothelial nitric oxide synthase phosphorylation in humans. Am J Physiol Heart Circ Physiol. 2017;313(4):H854–h9.
  • Buranaphatthana T, Apivatthakakul T, Apivatthakakul V. Anteromedial minimally invasive plate osteosynthesis (MIPO) for distal third humeral shaft fractures - Is it possible?: a cadaveric study. Injury. 2019;50(6):1166–1174.
  • Jenkins ND, Miller JM, Buckner SL, et al. Test-retest reliability of single transverse versus panoramic ultrasound imaging for muscle size and echo intensity of the biceps brachii. Ultrasound Med Biol. 2015;41(6):1584–1591.
  • Schoenfeld B, Contreras B. The muscle pump: potential mechanisms and applications for enhancing hypertrophic adaptations. Strength Cond J. 2014;36:21–25.
  • Kinsey AW, Ormsbee MJ. The health impact of nighttime eating: old and new perspectives. Nutrients. 2015;7(4):2648–2662.
  • Madzima TA, Panton LB, Fretti SK, et al. Night-time consumption of protein or carbohydrate results in increased morning resting energy expenditure in active college-aged men. Br J Nutr. 2014;111(1):71–77.
  • Witard OC, Wardle SL, Macnaughton LS, et al. Protein considerations for optimising skeletal muscle mass in healthy young and older adults. Nutrients. 2016;8(4):181.
  • Kalliokoski KK, Laaksonen MS, Takala TO, et al. Muscle oxygen extraction and perfusion heterogeneity during continuous and intermittent static exercise. J Appl Physiol. 2003;94(3):953–958.
  • Weber MA, Krakowski-Roosen H, Delorme S, et al. Relationship of skeletal muscle perfusion measured by contrast-enhanced ultrasonography to histologic microvascular density. J Ultrasound Med. 2006;25(5):583–591.
  • Kenward MG, Roger JH. The use of baseline covariates in crossover studies. Biostatistics. 2010;11(1):1–17.
  • Senn S. Cross-over trials in clinical research. 2nd ed. Chichester Eng: John Wiley & Sons; 2002.
  • Willavize SA, Morgenthien EA. Nonparametric confidence intervals for Tmax in sequence-stratified crossover studies. Pharm Stat. 2008;7(1):9–19.
  • Shepherd TA, Edelstyn NMJ, Longshaw L, et al. Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment. Pilot Feasibility Stud. 2018;4:11.
  • Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012;65(3):301–308.
  • Morita M, Hayashi T, Ochiai M, et al. Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability. Biochem Biophys Res Commun. 2014;454(1):53–57.
  • Böger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor. J Nutr. 2004;134(10):2842S–7S. discussion 53S.
  • Khalaf D, Krüger M, Wehland M, et al. The effects of oral l-arginine and l-citrulline supplementation on blood pressure. Nutrients. 2019;11(7):1679.
  • Böger RH, Bode-Böger SM, Thiele W, et al. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol. 1998;32(5):1336–1344.
  • Schwedhelm E, Maas R, Freese R, et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol. 2008;65:51–59.
  • Böger RH, Bode-Böger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol. 2001;41(1):79–99.
  • Fitzpatrick DF, Bing B, Maggi DA, et al. Vasodilating procyanidins derived from grape seeds. Ann N Y Acad Sci. 2002;957(1):78–89.
  • Lizarraga D, Lozano C, Briedé JJ, et al. The importance of polymerization and galloylation for the antiproliferative properties of procyanidin-rich natural extracts. Febs J. 2007;274(18):4802–4811.
  • Montagut G, Baiges I, Valls J, et al. A trimer plus a dimer-gallate reproduce the bioactivity described for an extract of grape seed procyanidins. Food Chem. 2009;116(1):265–270.
  • Fitzpatrick DF, Fleming RC, Bing B, et al. Isolation and characterization of endothelium-dependent vasorelaxing compounds from grape seeds. J Agric Food Chem. 2000;48(12):6384–6390.
  • Fitzpatrick DF Vasodilating compound and method of use. 2004 updated 2021 May 15. Available from: https://scholarcommons.usf.edu/usf_patents/748
  • 15 May 2021. Available from: https://seriousnutritionsolutions.com/product/vaso6-30-caps
  • Tao W, Zhang Y, Shen X, et al. Rethinking the mechanism of the health benefits of proanthocyanidins: absorption, metabolism, and interaction with gut microbiota. Compr Rev Food Sci Food Saf. 2019;18:971–985.
  • Serra A, Macià A, Romero MP, et al. Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models. Br J Nutr. 2010;103(7):944–952.
  • Spencer JP, Abd El Mohsen MM, Minihane AM, et al. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br J Nutr. 2008;99(1):12–22.
  • Holt RR, Lazarus SA, Sullards MC, et al. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am J Clin Nutr. 2002;76(4):798–804.
  • Funk RS, Singh RK, Winefield RD, et al. Variability in potency among commercial preparations of berberine. J Diet Suppl. 2018;15(3):343–351.
  • Chappell AJ, Allwood DM, Johns R, et al. Citrulline malate supplementation does not improve German volume training performance or reduce muscle soreness in moderately trained males and females. J Int Soc Sports Nutr. 2018;15(1):42.
  • Alvares TS, Oliveira GV, Soares R, et al. Near-infrared spectroscopy-derived total haemoglobin as an indicator of changes in muscle blood flow during exercise-induced hyperaemia. J Sports Sci. 2020;38(7):751–758.
  • Yanagisawa O, Kudo H, Takahashi N, et al. Magnetic resonance imaging evaluation of cooling on blood flow and oedema in skeletal muscles after exercise. Eur J Appl Physiol. 2004;91(5–6):737–740.
  • Steinach M, Lichti J, Maggioni MA, et al. A fluid shift for endurance exercise-Why hydration matters. Acta Physiol (Oxf). 2019;227(1):e13347.
  • Ploutz-Snyder LL, Convertino VA, Dudley GA. Resistance exercise-induced fluid shifts: change in active muscle size and plasma volume. Am J Physiol. 1995;269(3 Pt 2):R536–43.
  • Sjøgaard G, Saltin B. Extra- and intracellular water spaces in muscles of man at rest and with dynamic exercise. Am J Physiol. 1982;243:R271–80.
  • Cholewa J, Trexler E, Lima-Soares F, et al. Effects of dietary sports supplements on metabolite accumulation, vasodilation and cellular swelling in relation to muscle hypertrophy: a focus on “secondary” physiological determinants. Nutrition. 2019;60:241–251.
  • Stoll T, Huber E, Seifert B, et al. Maximal isometric muscle strength: normative values and gender-specific relation to age. Clin Rheumatol. 2000;19(2):105–113.
  • Toda N, Ayajiki K. Vascular actions of nitric oxide as affected by exposure to alcohol. Alcohol Alcohol. 2010;45(4):347–355.
  • Dankel SJ, Abe T, Bell ZW, Jessee MB, Buckner SL, and Mattocks KTet al, The Impact of Ultrasound Probe Tilt on Muscle Thickness and Echo-Intensity: A Cross-Sectional Study. J Clin Densitom. 2020;23(4):630–8.
  • Morel DR, Schwieger I, Hohn L, et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol. 2000;35(1):80–85.
  • Committee for Medicinal Products for Human Use (CHMP). Assessment report EMA/84084/2014. SonoVue. international non-proprietary name: sulfur hexafluoride, Procedure No. EMEA/H/C/000303/II/0025. 2014 updated 2021 May 15. Available from: https://www.ema.europa.eu/en/documents/variation-report/sonovue-h-c-303-ii-0025-epar-assessment-report-variation_en.pdf